Dr. Potenza is a board-certified psychiatrist with sub-specialty training and certification in addiction psychiatry. He trained at Yale University, receiving a combined BS/MS with Honors in Molecular Biochemistry and Biophysics and a PhD in Cell Biology, the latter concurrent with an MD through the Medical Scientist Training Program. Currently, he is a Professor of Psychiatry, Child Study and Neuroscience at the Yale University School of Medicine. He is also a CASAColumbia Senior Scientist and the Director of the Problem Gambling Clinic, the Center of Excellence in Gambling Research, and the Women and Addictive Disorders Core of Women’s Health Research at Yale.
Dr. Potenza’s research has focused on the neurobiology and treatment of substance and non-substance addictions and other disorders characterized by impaired impulse control and reward-related motivations. The majority of this work has focused on understanding clinical and neurobiological underpinnings of these disorders, and their co-occurrences with other mental health disorders, in order to advance prevention and treatment strategies. Dr. Potenza’s research has applied brain imaging, genetic, epidemiological and clinical trials methodologies to gain knowledge and improve prevention and treatment strategies for addictive disorders. This work has also involved identifying potential intermediary phenotypes, including facets of impulsivity, that may in part explain the high rates of co-occurrence among psychiatric conditions and might represent novel targets for prevention and treatment strategies.
Dr. Potenza is on the editorial boards of fourteen journals (including editor-in-chief of Current Addiction Reports) and has received multiple national and international awards for excellence in research and clinical care. He has consulted the Substance Abuse and Mental Health Services Administration, National Registry of Effective Programs, National Institutes of Health, American Psychiatric Association and World Health Organization on matters of addiction. He has participated in two DSM-5 research work groups, addressing topics relating to gambling, impulse control, and addiction.